Breaking News, Promotions & Moves

Pharm-Olam Appoints Robert Davie as CEO

Succeeds David Grange, positioning organization for continued growth

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharm-Olam, a global midsized contract research organization (CRO), has named Robert Davie, Ph.D., as its new chief executive officer. Pharm-Olam provides full-service clinical development solutions for oncology-hematology, infectious disease, vaccines, and rare diseases.   Davie succeeds David Grange who has served as Pharm-Olam’s chief executive since April 2017. Grange will remain a director and vice chairman of the company’s board and will continue to support the organization and its work in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters